...
首页> 外文期刊>International immunopharmacology >Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.
【24h】

Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.

机译:肾激肽释放酶激肽系统在大鼠常染色体显性多囊肾疾病中的活性增加,但在人类中却没有。

获取原文
获取原文并翻译 | 示例

摘要

The kallikrein-kinin system (KKS) was investigated in autosomal dominant polycystic kidney disease (ADPKD)-affected rats (PKD) and compared to unaffected controls (SD) and 5/6 nephrectomized rats (5/6 Nx). In addition, patients with ADPKD compared to patients with nonpolycystic kidney disease and healthy controls have been investigated. Plasma and urine samples for determination of creatinine, protein, kallikrein (KAL) and bradykinin (BK) were taken in male 3- and 9-month-old PKD, SD and 9-month-old 5/6 Nx. The same parameters were determined in young (age: 20-40 years) and old (41-65 years) male patients with ADPKD and compared to age-matched patients with nonpolycystic kidney disease and age-matched healthy controls. Plasma and urine KAL were measured by chromogenic peptide substrate, and kininswere determined by radioimmunoassay. Urine KAL and BK levels were increased i n PKD compared to age-matched SD. No differences with respect to serum KAL were found between PKD and SD. In 5/6 Nx, urinary BK levels showed a trend towards higher compared to old SD (p = 0.06). KAL and BK were not increased in serum and urine of patients with ADPKD, in contrast to rats. Urinary KAL excretion was reduced in patients with ADPKD and advanced renal failure. Our results demonstrate an age-dependent activation of the renal KKS in rats with ADPKD, whereas the KKS is not activated in patients with ADPKD and advanced renal failure. These data indicate that there are fundamental differences in the factors influencing the course of the disease in human and rat ADPKD.
机译:在常染色体显性多囊肾病(ADPKD)感染的大鼠(PKD)中研究了激肽释放酶激肽系统(KKS),并与未受影响的对照(SD)和5/6肾切除的大鼠(5/6 Nx)进行了比较。此外,与非多囊性肾病患者和健康对照相比,ADPKD患者进行了研究。在男性和3个月大和9个月大的PKD,SD和9个月大的5/6 Nx中采集血浆和尿液样本,以测定肌酸酐,蛋白质,激肽释放酶(KAL)和缓激肽(BK)。在年轻(年龄:20-40岁)和老年(41-65岁)ADPKD男性患者中确定了相同的参数,并将其与年龄匹配的非多囊肾病患者和年龄匹配的健康对照者进行了比较。用生色肽底物测量血浆和尿液中的KAL,用放射免疫法测定激肽。与年龄相匹配的SD相比,PKD中尿液中的KAL和BK水平升高。在PKD和SD之间未发现血清KAL的差异。在5/6 Nx中,尿BK水平显示出比旧SD更高的趋势(p = 0.06)。与大鼠相反,ADPKD患者的血清和尿液中的KAL和BK并未增加。 ADPKD和晚期肾功能衰竭患者的尿KAL排泄减少。我们的结果表明,ADPKD大鼠肾脏KKS的年龄依赖性激活,而ADPKD和晚期肾衰竭的患者KKS未被激活。这些数据表明,影响人类和大鼠ADPKD疾病进程的因素存在根本差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号